Women's Health Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Ankara Etlik Maternity & Women's Health Teaching Hospital
Pregnancy-related anemia responds quicker to i.v. than to oral iron therapy
February 5th, 2006
Preganancy-related anemia responds quicker to intravenous compared to oral iron therapy. Scientists in Turkey report, "The aim of this study was to compare the efficacy of intravenous iron to oral iron in the treatment of anemia in pregnancy." R.A. Al and colleagues explained, "In this randomized open-label study, 90 women with hemoglobin levels between 8 and 10.5 g/dL and ferritin values less than 13 mcg/L received either oral iron polymaltose complex (300 mg elemental iron per day) or intravenous iron sucrose. The iron sucrose dose was calculated from the following formula: weight before pregnancy (kg) x (110 g/L -actual hemoglobin [g/L]) x 0.24 +...
Source: Women's Health Law Weekly (2006-02-05)
|
